| CANDRIAM EQUITIES L BIOTECHNOLOGY V CAP USD | BIOTECNOLOGÍA | 40,35% | 53,38% | 63,26% | 201,58% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY C CAP USD | BIOTECNOLOGÍA | 40,32% | 51,87% | 61,19% | 190,33% |
| BGF JAPAN SMALL & MIDCAP OPPORTUNITIES A2 EUR (HEDGED) | RVI JAPÓN SMALL/MID CAP | 40,22% | 100,55% | 81,42% | 179,02% |
| POLAR CAPITAL JAPAN VALUE S CHF DIS HEDGED | RVI JAPÓN VALOR | 40,21% | 110,07% | 174,02% | · |
| FIDELITY FUNDS-LATIN AMERICA A-ACC-EUR | RVI LATINOAMÉRICA | 40,20% | 45,78% | 45,75% | 72,88% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | BIOTECNOLOGÍA | 40,17% | 52,83% | 62,27% | 197,65% |
| PICTET - CLEAN ENERGY TRANSITION HR EUR | ENERGÍA | 40,17% | 35,81% | 17,62% | · |
| SCHRODER ISF JAPANESE SMALLER COMPANIES C ACC EUR (HEDGED) | RVI JAPÓN SMALL/MID CAP | 40,17% | 59,64% | 48,97% | · |
| NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY USD A ACC | TMT | 40,16% | 105,59% | 52,97% | · |
| JPM LATIN AMERICA EQUITY D (ACC) EUR | RVI LATINOAMÉRICA | 40,10% | 47,20% | 61,99% | 89,31% |
